Profile: IDCRC Mentee Zanthia Wiley, MD

“I could not be more proud of our IDCRC mentee, Dr. Zanthia Wiley, and the incredible work she is doing for COVID clinical care, research, community engagement.” - Nadine Rouphael, MD, Emory VTEU PI and Wiley’s IDCRC mentor

“Dr. Wiley is incredible and a leader in our group of mentees. It makes me proud to think that she will be continuing and extending our work to people of all racial and ethnic groups.” - Kathryn Edwards, MD, IDCRC Mentoring and Career Development Committee Chair

Training

Inaugural New Investigator Pilot Award Recipients

The IDCRC New Investigator Pilot Awards recently funded two research projects to enhance early stage investigators' ability to compete successfully for an independent R- or K-series award. The inaugural recipients are:

Mentoring Lecture Series

IDCRC/VTEU Overview: How does it work?

Presenters:

• Dr. Kathy Neuzil, University of Maryland
• Dr. David Stephens, Emory University
• Dr. Emily Erbelding, Director, NIAID Division of Microbiology and Infectious Diseases

In The News

First participant enrolled in Gritstone second generation COVID-19 vaccine study

Published March 25, 2021

An early phase clinical trial is being conducted through the NIAID-supported Infectious Diseases Clinical Research Consortium (IDCRC) to assess the safety and tolerability of different doses of two-part investigational COVID-19 vaccine regimens that include bits of other SARS-CoV-2 proteins in addition to the spike.

Investigational AstraZeneca vaccine prevents COVID-19

Published March 22, 2021

Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization. 

Kaiser Permanente: Looking back: Our COVID-19 vaccine trial at 1 year

Published March 2021

Dr. Rita Mangione-Smith reflects on the year since KPWHRI launched the world's first clinical trial for a COVID-19 vaccine. Mangione-Smith is vice president for research and health care innovation at Kaiser Permanente Washington, executive director and senior investigator of Kaiser Permanente Washington Health Research Institute, and professor of health systems science at Kaiser Permanente School of Medicine.

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine

Published February 27, 2021

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725. 

Publications

• Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
• Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
• Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
• Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled

Event

Conducting Sexually Transmitted Infection Research in Women of Reproductive Age: An Interdisciplinary Discussion of Experience, Strategies & Policies to Advance the Field

April 27-28 2021

The University of Alabama at Birmingham Sexually Transmitted Infections (STI) Clinical Trials Group presents this 2021 programmatic meeting on STI research in women of reproductive age, especially pregnant and lactating women. IDCRC encourages those interested to attend. This event is organized by Jeanne Marrazzo, and features Kathy Neuzil and Flor Munoz, who will address issues of vaccine research, particularly in pregnancy, and Annie Lyerly from the IDCRC EAB. Contact jmarrazzo@uabmc.edu with questions.

IDCRC Studies

IDCRC Concept Quick Stats

Communication Resources

• Access new IDCRC YouTube channel

Please submit IDCRC news to epthomp@emory.edu for inclusion in the monthly newsletter and IDCRC.org.